MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 123 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 11.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $222,000 | -27.0% | 3,100 | 0.0% | 0.06% | -22.8% |
| Q1 2022 | $304,000 | -36.0% | 3,100 | -44.6% | 0.08% | -33.6% |
| Q4 2021 | $475,000 | +6.3% | 5,600 | 0.0% | 0.12% | 0.0% |
| Q3 2021 | $447,000 | -18.0% | 5,600 | 0.0% | 0.12% | +4.4% |
| Q2 2021 | $545,000 | -16.8% | 5,600 | 0.0% | 0.11% | -26.5% |
| Q1 2021 | $655,000 | -10.8% | 5,600 | -15.2% | 0.16% | -28.9% |
| Q4 2020 | $734,000 | -6.4% | 6,600 | 0.0% | 0.22% | -14.5% |
| Q3 2020 | $784,000 | +5.0% | 6,600 | 0.0% | 0.26% | +18.1% |
| Q2 2020 | $747,000 | -17.7% | 6,600 | -51.5% | 0.22% | -43.0% |
| Q1 2020 | $908,000 | -26.7% | 13,600 | 0.0% | 0.38% | -10.8% |
| Q4 2019 | $1,239,000 | +117.8% | 13,600 | +106.1% | 0.42% | +98.6% |
| Q3 2019 | $569,000 | -17.8% | 6,600 | 0.0% | 0.21% | -17.7% |
| Q2 2019 | $692,000 | -16.3% | 6,600 | 0.0% | 0.26% | -27.2% |
| Q1 2019 | $827,000 | +11.2% | 6,600 | 0.0% | 0.36% | -3.5% |
| Q4 2018 | $744,000 | – | 6,600 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |